David J. Wambeke - Chief Business Officer at DiaMedica Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
DMAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

David J. Wambeke - trading volume in the past year for DiaMedica Therapeutics Inc.

Holdings reported by David J. Wambeke for DiaMedica Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Voting Common Shares, no par value per share 527,114 $1.48 M $2.80 Jun 1, 2024 Direct
Stock Option (right to buy) 130,000 Jun 1, 2024 Direct Common Shares

Transactions reported by David J. Wambeke for DiaMedica Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership